Active Ingredient History

NOW
  • Now
Eliprodil is an NMDA antagonist drug candidate which selectively inhibits the NR2B (GLUN2B) subtype NMDA receptor at submicromolar concentrations. Eliprodil failed a Phase III clinical trial for the treatment of acute ischemic stroke in 1996, sponsored by Synth√©labo Recherche.   Wikipedia

  • SMILES: OC(CN1CCC(Cc2ccc(F)cc2)CC1)c3ccc(Cl)cc3
  • InChIKey: GGUSQTSTQSHJAH-UHFFFAOYSA-N
  • Mol. Mass: 347.86
  • ALogP: 4.47
  • ChEMBL Molecule:
More Chemistry
1-piperidineethanol, alpha-(4-chlorophenyl)-4-(4-fluorophenyl)-, (+-)- | (4-chlorophenyl)-4-((4-fluorophenyl)methyl)-1-piperidineethanol | eliprodil | sl 82-0715 | sl 82.0715 | sl-820715

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue